Chi-Ming Che Selected Research

tetraphenylporphyrin

5/2013	A gold(III) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells.
6/2011	Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.
8/2010	Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-Ming Che Research Topics

Disease

58	Neoplasms (Cancer) 12/2021 - 07/2003
10	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 04/2005
7	Carcinoma (Carcinomatosis) 09/2020 - 12/2003
6	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2006
5	Nasopharyngeal Carcinoma 06/2011 - 07/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2019
4	Insulin Resistance 01/2019 - 12/2010
4	Inflammation (Inflammations) 05/2015 - 01/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 12/2007
3	Breast Neoplasms (Breast Cancer) 06/2013 - 01/2010
3	Neuroblastoma 01/2012 - 01/2010
3	Wounds and Injuries (Trauma) 03/2010 - 01/2007
2	Carcinogenesis 01/2017 - 01/2012
2	Necrosis 04/2010 - 08/2005
2	Burns 07/2009 - 01/2007
2	Leukemia 12/2007 - 04/2006
1	Rheumatoid Arthritis 01/2020
1	Obesity 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 03/2017
1	Alzheimer Disease (Alzheimer's Disease) 05/2016
1	Goiter 08/2015
1	Glucose Intolerance 05/2015
1	Dyslipidemias (Dyslipidemia) 05/2015
1	Hyperglycemia 05/2015

Drug/Important Bio-Agent (IBA)

29	GoldIBA 10/2020 - 07/2003
11	PorphyrinsIBA 10/2020 - 07/2003
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2006
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2003
9	LigandsIBA 01/2018 - 02/2005
8	PlatinumIBA 12/2021 - 10/2005
8	Pharmaceutical PreparationsIBA 03/2017 - 07/2003
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2003
6	carbeneIBA 01/2021 - 06/2010
4	Biological ProductsIBA 12/2021 - 03/2010
4	LipidsIBA 05/2015 - 12/2010
4	gold (III) porphyrin 1aIBA 06/2011 - 01/2006
3	Sulfhydryl Compounds (Thiols)IBA 01/2020 - 03/2013
3	IronIBA 02/2015 - 09/2005
3	tetraphenylporphyrinIBA 05/2013 - 08/2010
3	SilverIBA 03/2010 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 12/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2016
2	ProteomeIBA 11/2019 - 02/2006
2	Therapeutic UsesIBA 10/2019 - 01/2010
2	HydrogelsIBA 03/2019 - 07/2015
2	PalladiumIBA 01/2018 - 01/2016
2	CateninsIBA 01/2018 - 01/2011
2	MetalsIBA 01/2017 - 07/2006
2	RutheniumIBA 10/2016 - 11/2007
2	Peptides (Polypeptides)IBA 05/2016 - 08/2005
2	Biotin (Vitamin H)FDA Link 05/2015 - 01/2013
2	Sirtuin 1IBA 05/2015 - 01/2013
2	phosphine (phosphane)IBA 09/2011 - 07/2006
2	SolventsIBA 06/2011 - 02/2005
2	PoisonsIBA 01/2011 - 06/2010
2	CytokinesIBA 12/2010 - 01/2007
2	Coordination ComplexesIBA 11/2010 - 11/2007
2	Phenylalanine (L-Phenylalanine)FDA Link 06/2009 - 02/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2008 - 12/2007
2	dioscinIBA 12/2007 - 04/2006
1	VimentinIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	SulfurIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Ubiquitinated ProteinsIBA 01/2020
1	Protein AggregatesIBA 01/2020
1	diphosphoric acid (pyrophosphoric acid)IBA 11/2019
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2019
1	Mevalonic Acid (Mevalonate)IBA 11/2019
1	Auranofin (Ridaura)FDA Link 11/2019
1	mevalonolactoneIBA 11/2019
1	Galectin 1 (LGALS1)IBA 10/2019
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 10/2019
1	compound 0118IBA 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 10/2019
1	Complement System Proteins (Complement)IBA 03/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2019
1	GelatinIBA 03/2019
1	AsparagineIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	SelenocysteineIBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017
1	Drug CarriersIBA 03/2017
1	EstersIBA 03/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2016
1	genipinIBA 07/2016
1	Amyloid (Amyloid Fibrils)IBA 05/2016
1	Coloring Agents (Dyes)IBA 05/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	2,2'-Dipyridyl (2,2 Bipyridine)IBA 01/2016
1	ClathrinIBA 08/2015
1	CollagenIBA 05/2015
1	CaspasesIBA 02/2015

Therapy/Procedure

4	Therapeutics 05/2016 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 04/2009
3	Intraperitoneal Injections 10/2009 - 03/2006
2	Injections 03/2019 - 01/2010
1	Precision Medicine 09/2020